Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in:

Open Access 01-12-2024 | Research

Interaction of proteinuria and diabetes on the risk of cardiovascular events: a prospective cohort CKD-ROUTE study

Authors: Shahi Kishor, Jianrong Chen, Yan Zhang, Wei Liu, Lingyan Zhu, Jixiong Xu, Jiancheng Wang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Objective

We evaluated the interaction of urinary protein-to-creatinine ratio (UPCR) with diabetes on the risk of cardiovascular events in a cohort study.

Methods

The study population consisted of 639 participants with chronic kidney disease (CKD) stages 2–5, enrolled between 2010 and 2011 in Japan. Cox proportional hazards models were used to evaluate the independent and combined effects of the UPCR and diabetes on cardiovascular events.

Results

During a median follow-up of 3 years, 59 participants developed cardiovascular events during follow-up. A notably higher risk of cardiovascular events was found in participants with proteinuria [hazards ratio (HR): 2.16, 95% confidence interval (95% CI): 1.17–3.97] compared to those without proteinuria at UPCR levels. In addition, the participants with diabetes had a higher risk of cardiovascular events (HR: 2.53, 95% CI: 1.49–4.30) than those without diabetes. Moreover, an interaction was found between UPCR and diabetes on cardiovascular events (P for interaction = 0.04). Participants with both proteinuria (UPCR ≥ 0.5 g/gCr) and diabetes had a 4.09 times higher risk of cardiovascular events (HR: 4.09, 95% CI: 1.97–8.47) compared with those without proteinuria (UPCR < 0.5 g/gCr) and diabetes.

Conclusions

In summary, among participants with CKD stages 2–5, proteinuria and diabetes were found to independently and jointly affect the risk of cardiovascular events. Participants with proteinuria and diabetes had the highest risk of cardiovascular events compared with other groups.
Appendix
Available only for authorised users
Literature
1.
Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.CrossRefPubMedPubMedCentral
2.
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 update: a Report from the American Heart Association. Circulation. 2023;147(8):e93–621.CrossRefPubMed
3.
Huxley R, Barzi F, Woodward M, et al. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–8.CrossRefPubMedPubMedCentral
4.
An Y, Zhang P, Wang J, et al. Cardiovascular and all-cause Mortality over a 23-Year period among Chinese with newly diagnosed diabetes in the Da Qing IGT and Diabetes Study. Diabetes Care. 2015;38(7):1365–71.CrossRefPubMedPubMedCentral
5.
6.
Giugliano D, Maiorino M, Bellastella G, et al. Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk. Endocrine. 2018;61(1):23–7.CrossRefPubMed
7.
Morales J, Handelsman Y. Cardiovascular outcomes in patients with diabetes and kidney disease: JACC Review topic of the Week. J Am Coll Cardiol. 2023;82(2):161–70.CrossRefPubMed
8.
Howard BV, Magee MF. Diabetes and cardiovascular disease. Curr Atheroscler Rep. 2000;2(6):476–81.CrossRefPubMed
9.
Liu JE, Robbins DC, Palmieri V, et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the strong heart study. J Am Coll Cardiol. 2003;41(11):2022–8.CrossRefPubMed
10.
Valmadrid CT, Klein R, Moss SE, et al. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med. 2000;160(8):1093–100.CrossRefPubMed
11.
Iimori S, Noda Y, Okado T, et al. Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study. BMC Nephrol. 2013;14:152.CrossRefPubMedPubMedCentral
12.
Iimori S, Naito S, Noda Y, et al. Prognosis of chronic kidney disease with normal-range proteinuria: the CKD-ROUTE study. PLoS ONE. 2018;13(1):e0190493.CrossRefPubMedPubMedCentral
13.
Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRefPubMed
14.
Wang A, Sun Y, Liu X, et al. Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study. Cardiovasc Diabetol. 2017;16(1):104.CrossRefPubMedPubMedCentral
15.
Scirica BM, Mosenzon O, Bhatt DL, et al. Cardiovascular outcomes according to urinary albumin and kidney disease in patients with type 2 diabetes at High Cardiovascular Risk: observations from the SAVOR-TIMI 53 Trial. JAMA Cardiol. 2018;3(2):155–63.CrossRefPubMed
16.
Chauhan S, Ghosh M, Agrawal P, et al. Prevalence of silent myocardial ischemia in type 2 diabetes mellitus with microalbuminuria. Int J Adv Med. 2017;4(1):40–6.
17.
Fukui M, Kitagawa Y, Nakamura N, et al. Association between urinary albumin excretion and serum dehydroepiandrosterone sulfate concentration in male patients with type 2 diabetes: a possible link between urinary albumin excretion and cardiovascular disease. Diabetes Care. 2004;27(12):2893–7.CrossRefPubMed
18.
Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145–53.CrossRef
19.
Zeeuw DE, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921–7.CrossRefPubMed
20.
Howard BV, Lee ET, Cowan LD, et al. Rising tide of cardiovascular disease in American indians. The strong heart study. Circulation. 1999;99(18):2389–95.CrossRefPubMed
21.
Marcovecchio ML, Chiesa ST, Armitage J, et al. Renal and Cardiovascular Risk according to Tertiles of urinary albumin-to-creatinine ratio: the adolescent type 1 diabetes cardio-renal intervention trial (AdDIT). Diabetes Care. 2018;41(9):1963–9.CrossRefPubMed
22.
23.
Aso Y. Cardiovascular disease in patients with diabetic nephropathy. Curr Mol Med. 2008;8(6):533–43.CrossRefPubMed
24.
Sheer R, Nair R, Pasquale MK, et al. Predictive risk models to identify patients at high-risk for severe clinical outcomes with chronic kidney disease and type 2 diabetes. J Prim Care Community Health. 2022;13:21501319211063726.CrossRefPubMedPubMedCentral
25.
Yang X, Ko GTC, So WY, et al. Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry. Diabetes Care. 2008;31(12):2294–300.CrossRefPubMedPubMedCentral
26.
Nochioka K, Sakata Y, Miura M, et al. Impaired glucose tolerance and albuminuria in patients with chronic heart failure: a subanalysis of the SUPPORT trial. ESC Heart Fail. 2019;6(6):1252–61.CrossRefPubMedPubMedCentral
27.
Wong WT, Wong SL, Tian XY, et al. Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol. 2010;55(4):300–7.CrossRefPubMed
28.
29.
Steckelings UM, Rompe F, Kaschina E, et al. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol. 2010;23(6):693–703.CrossRef
30.
Rahman A, Sherajee SJ, Rafiq K, et al. The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats. J Pharmacol Sci. 2020;142(3):124–6.CrossRefPubMed
31.
Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab. 2000;26(Suppl 4):64–6.PubMed
32.
Koppe L, Nyam E, Vivot K, et al. Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease. J Clin Invest. 2016;126(9):3598–612.CrossRefPubMedPubMedCentral
33.
Tuttle KR, Brosius FC, Cavender MA, et al. SGLT2 inhibition for CKD and Cardiovascular Disease in Type 2 diabetes: report of a Scientific Workshop Sponsored by the National Kidney Foundation. Diabetes. 2021;70(1):1–16.CrossRefPubMed
Metadata
Title
Interaction of proteinuria and diabetes on the risk of cardiovascular events: a prospective cohort CKD-ROUTE study
Authors
Shahi Kishor
Jianrong Chen
Yan Zhang
Wei Liu
Lingyan Zhu
Jixiong Xu
Jiancheng Wang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-20715-2

Other articles of this Issue 1/2024

Effects of perceived stress on turnover intention of female healthcare staff: a serial multiple mediation model

Relationship between rest–activity rhythms and cardiorespiratory fitness in middle-aged workers: a cross-sectional study with non-parametric analysis using accelerometers worn on the thigh

  • Open Access
  • Research

Sexual violence against ever-married reproductive-age women in East Africa: further analysis of recent demographic and health surveys

  • Open Access
  • Research

Exploring risky health behaviors and vulnerability to sexually transmitted diseases among transnational undocumented labor migrants from Bangladesh: a qualitative study

Long-term health related quality of life in adult extracorporeal membrane oxygenation survivors: a single-centre, cross-sectional study

  • Open Access
  • Research

Frequency of cigarette smoking and its associated factors among men in East Africa: a pooled prevalence analysis of national survey using multinomial regression